Form 4: Third Harmonic Bio COO Jennifer Dittman Receives Stock Options and Restricted Stock Units

Third Harmonic Bio's Chief Operating Officer, Jennifer Dittman, was granted stock options and restricted stock units as part of the company's annual equity refresh.

Summary

• Jennifer Dittman, Chief Operating Officer of Third Harmonic Bio, received equity awards including stock options and restricted stock units.
• The stock options grant is for 92,000 shares with an exercise price of $6.
• The options vest over four years, with an initial 2.0833% vesting on February 15, 2025, and the remainder vesting monthly.
• Dittman also received 11,500 restricted stock units (RSUs), each representing one share of common stock.
• The RSUs vest over four years, with 1/4 vesting on February 15, 2026, and the remainder vesting annually.

Sentiment

Score: 7

Explanation: The document reflects a routine equity grant, which is generally positive for aligning management interests with shareholders, but not a major event.

Positives

• The equity grants align the COO's interests with the company's long-term performance.
• The vesting schedule encourages continued service and commitment from the COO.

Future Outlook

The vesting schedules for both the stock options and RSUs are contingent upon continued service with the company.

Industry Context

Equity grants are a common practice in the biotechnology industry to attract and retain key executives.

Comparison to Industry Standards

• Equity grants are a standard form of compensation for executives in the biotech industry, often including a mix of stock options and restricted stock units.
• Vesting schedules are typically structured to incentivize long-term commitment, with four-year vesting periods being common.
• The specific amounts and terms of the grants are likely based on the executive's role, performance, and industry benchmarks.

Stakeholder Impact

• The equity grants align the COO's interests with those of shareholders.
• The vesting schedule encourages the COO's continued service, which benefits the company and its stakeholders.

Key Dates

Keywords

stock options, restricted stock units, equity compensation, executive compensation, vesting, Third Harmonic Bio, THRD, Jennifer Dittman